Co-Diagnostics (NASDAQ:CODX) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) in a report published on Friday morning, TipRanks reports. The firm currently has a $15.00 target price on the stock. A number of other research firms have also recently commented on CODX. Sidoti began coverage on shares of Co-Diagnostics in a […]

Related Keywords

Tennessee ,United States , ,Goldman Sachs Group Inc ,Zacks Investment Research ,Parametric Portfolio Associates ,Wells Fargo Company ,Diagnostics Company Profile Get Rating ,Diagnostics Inc ,Cubist Systematic Strategies ,Tennessee Treasury Department ,Get Rating ,Investment Research ,Sachs Group ,Portfolio Associates ,Systematic Strategies ,Diagnostics Company Profile ,Co Diagnostics ,Nasdaq Codx ,Codx ,Medical ,Reiterated Rating ,Hc Wainwright ,